Breaking News
0

Array BioPharma Inc (ARRY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Array BioPharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
46.490 0.000    0.00%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
46.490
0.000
0.000%
16:04:08 - Real-time Data
Type: Equity
Market: United States
ISIN: US04269X1054 
CUSIP: 04269X105
  • Volume: 4,158,183
  • Bid/Ask: 46.440 / 46.700
  • Day's Range: 46.340 - 46.660
Array BioPharma 46.490 0.000 0.00%

ARRY Overview

 
Information about the Array BioPharma Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close46.49
Day's Range46.34 - 46.66
Revenue239.58M
Open46.45
52 wk Range12.56 - 47.05
EPS - 0.59
Volume4,158,183
Market Cap10.31B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)5,807,578
P/E RatioN/A
Beta1.64
1-Year Change175.25%
Shares Outstanding221,750,763
Next Earnings DateAug 13, 2019
What is your sentiment on Array BioPharma?
or
Market is currently closed. Voting is open during market hours.

Array BioPharma Inc News


Array BioPharma Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Sell Buy Buy
Technical Indicators Strong Sell Strong Sell BUY Neutral BUY
Summary Strong Sell Strong Sell Neutral Neutral Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Engulfing Bearish 1H Current
Completed Patterns
Engulfing Bearish 1M 3 Apr 19
Evening Doji Star 1M 12 Jul 18
Falling Three Methods 1M 12 Jul 18

Array BioPharma Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 46.490 46.440 46.700 4,158,183 0.00% USD 15:59:59  
  CBOE 46.48 0.00 0.00 430,711 0.00% USD 15:59:53  
  Stuttgart 41.210 22.590 24.095 0 0.00% EUR 18/07  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 202.59 206.50 202.36 -3.07 -1.49% 19.98M 15:59:59  
  Facebook 198.36 202.33 198.13 -2.42 -1.21% 11.49M 16:00:01  
  Alphabet A 1,131.55 1,151.58 1,131.25 -15.69 -1.37% 1.15M 15:59:59  
  Tesla 258.18 259.96 254.62 +4.64 +1.83% 6.98M 15:59:59  
  Amazon.com 1,964.52 1,996.00 1,962.23 -13.38 -0.68% 3.14M 15:59:59  
  AMD 32.51 33.35 32.45 -0.49 -1.48% 44.28M 15:59:59  
  Microsoft 136.62 140.67 136.45 +0.20 +0.15% 48.54M 15:59:59  
  Alibaba ADR 173.01 175.15 173.00 +0.21 +0.12% 12.84M 16:00:00  
  Beyond Meat 176.79 178.55 170.77 +6.45 +3.79% 4.24M 16:00:01  
  NVIDIA 168.44 171.98 168.20 -1.74 -1.02% 8.46M 15:59:59  

Array BioPharma Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

298

Equity Type

ORD

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. The Company's programs include approximately three cancer drugs, binimetinib, encorafenib and selumetinib (partnered with AstraZeneca, PLC). Its binimetinib and encorafenib are in Phase III trials in advanced cancer patients, including the COLUMBUS trial studying encorafenib in combination with binimetinib in patients with BRAF-mutant melanoma and has initiated BEACON CRC trial to study encorafenib in combination with binimetinib and cetuximab in patients with BRAF V600E-mutant colorectal cancer (BRAFm CRC). Its selumetinib is a mitogen-activated protein kinase (MEK) inhibitor for cancer, which is in Phase III trial. Its advanced clinical-stage drugs include Filanesib, ARRY-797, ASC08/Danoprevir, Ipatasertib/GDC-0068, Motolimod/VTX-2337, LOXO-101, ONT-380/ARRY-380, GDC-0575, GDC-0994 and ARRY-382.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARRY Comments

Write your thoughts about Array BioPharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jeff Bailey
Jeff Bailey Jun 17, 2019 1:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Selling to close ARRY Jan17 2020 $25 C @ $21.90.
Mark Stone
Mark Stone Jun 17, 2019 8:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Spent to much time watching, not enough buying
Jeff Bailey
Jeff Bailey Jun 06, 2019 5:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARRY $27.78 -0.07% ... Printed a doji on 6/5/19. might be time to take a rest and consolidate.
Jeff Bailey
Jeff Bailey May 21, 2019 1:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARRY $25.40 +21%
WTI Trader
WTI Trader May 21, 2019 1:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good for you!
Abhishek M R
Abhishek M R Jul 24, 2013 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARRY Is a Buy @ 6.18 - 6 for target 7.10 - 7.40 , stops below 5.8 #stocks #mkt #trade
Jeff Bailey
Jeff Bailey Jul 24, 2013 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice!  $20.73 today and new 52-weeker!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email